This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: Neurosolis, Inc.. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Innovations of Trevor M Twose in Cognitive Enhancement
Introduction
Trevor M Twose is an accomplished inventor based in Fitchburg, WI (US). He has made significant contributions to the field of cognitive enhancement through his innovative inventions. With a total of 4 patents, Twose has focused on developing compounds and methods that aim to improve cognitive function.
Latest Patents
One of Trevor M Twose's latest patents is centered around cognition-enhancing compounds and compositions. This invention relates to muscarinic agonists, which are useful for stimulating muscarine receptors and treating cognitive disorders. Among the muscarinic agonists disclosed are oxadiazole derivatives, along with their compositions and preparations. The patent also provides methods for synthesizing these oxadiazole compounds. Furthermore, it discusses compositions designed to enhance cognitive function in subjects, including humans, which comprise a muscarinic agonist or a pharmaceutically suitable form thereof. The methods outlined in this patent also pertain to treating animals, such as humans, by administering these compositions.
Career Highlights
Trevor M Twose is currently associated with Neurosolis, Inc., where he continues to innovate in the field of cognitive enhancement. His work has garnered attention for its potential applications in treating cognitive disorders and improving mental function.
Collaborations
Some of his notable coworkers include Michael L Hendrickson and Brent D Abraham, who contribute to the collaborative efforts at Neurosolis, Inc. Their combined expertise enhances the innovative environment in which Twose operates.
Conclusion
Trevor M Twose's contributions to cognitive enhancement through his patents and work at Neurosolis, Inc. highlight his commitment to advancing the field. His innovative approaches to muscarinic agonists and cognitive function represent significant strides in medical science.